Stockreport

https://seekingalpha.com/article/4765804-sagimet-biosciences-denifanstat-should-be-worth-more-today [Seeking Alpha]

Sagimet Biosciences Inc. - Series A  (SGMT) 
PDF SGMT also has a diversified pipeline on acne, solid tumors, and GBM, enhancing its optionality beyond its primary MASH focus. They've recently shown some positive tri [Read more]